Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganshuang granules for hepatitis B-related cirrhosis
ChiCTR2000034262Phase 4Completed
- Sponsor
- Gansu Second Provincial People's Hospital
- Start
- Feb 2017
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Ganshuang Keli in Cirrhosis and Chronic Hepatitis B (CHB), sponsored by Gansu Second Provincial People's Hospital. Primary endpoints: ALT, AST and 7 more. Started Feb 2017; status: completed.
02
Drugs
Ganshuang Keli
03
Conditions
CirrhosisChronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2000034262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034262.